Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled Study

Study ID: NCT07479407
Start Date: 2026-04
End Date: 2029-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

74

Intervention / Treatment

Preoperative Exercise Training

Sponsor

Valais Hospital

Source: clinicaltrials.gov

Share:
Add to list

Glaucoma Drop Aids Part 2

Study ID: NCT06806332
Start Date: 2026-04
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Nanodropper

Sponsor

Boston Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury

Study ID: NCT05217498
Start Date: 2027-09-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Istradefylline

low oxygen therapy

Sponsor

Randy Trumbower, PT, PhD

Source: clinicaltrials.gov

Share:
Add to list

Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario

Study ID: NCT02177721
Start Date: 2027-01
End Date: 2035-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

Sample Collection

Sponsor

Emergent BioSolutions

Source: clinicaltrials.gov

Share:
Add to list

Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

Study ID: NCT06876038
Start Date: 2026-09
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

65

Intervention / Treatment

5-Amino Levulinic Acid

Sponsor

University of Massachusetts, Boston

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma

Study ID: NCT07367685
Start Date: 2026-05-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

6

Intervention / Treatment

QH103 Cell Injection

Cyclophosphamide

Fludarabine

Sponsor

The Second Affiliated Hospital of Fujian Medical University

Source: clinicaltrials.gov

Share:
Add to list

Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis

Study ID: NCT07391449
Start Date: 2027-01-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

240

Intervention / Treatment

HRV-guided home exercise prescription

Traditional Home Exercise

Sponsor

The Hong Kong Polytechnic University

Source: clinicaltrials.gov

Share:
Add to list

BPL-1357 Against H1N1 Influenza Virus Challenge

Study ID: NCT07215858
Start Date: 2026-03-29
End Date: 2028-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

126

Intervention / Treatment

BPL-1357 IM

BPL-1357 IN

Placebo IM

Placebo IN

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients

Study ID: NCT06907485
Start Date: 2026-08
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Aminolevulinic acid hydrochloride

Sponsor

Costas Hadjipanayis

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis*

Study ID: NCT07339163
Start Date: 2026-04-01
End Date: 2035-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)

Sponsor

Ohio State University

Source: clinicaltrials.gov

Share:
Add to list